Researchers have identified a specific set of molecules produced by gut bacteria that travel directly to the liver and play a critical role in regulating the body’s energy consumption and insulin sensitivity. The composition of these metabolites changes based on diet and genetics, directly influencing how the liver processes blood sugar. This discovery, published in Cell Metabolism, opens up new pathways for therapeutic strategies targeting the gut microbiome to prevent or manage metabolic disorders like obesity and type 2 diabetes. Source: Harvard University / FAPESP
Link: https://www.sciencedaily.com/releases/2025/12/251214100926.htm
Leave a Reply